Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaoru Tsuchiya

Showing results (61-70 of 149) with videos related to

Pageof 15
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2018
Prediction of Hepatocellular Carcinoma After Sustained Virological Responses Using Magnetic Resonance ElastographyMayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Liver Cancer|October 9, 2025
Primary Analysis of a Phase II Study of Atezolizumab plus Bevacizumab for TACE-Unsuitable Patients with Tumor Burden beyond Up-To-Seven Criteria in Intermediate-Stage Hepatocellular Carcinoma: REPLACEMENT StudyMasatoshi Kudo, Kazuomi Ueshima, Kaoru Tsuchiya, et al.
Hepatology Communications|September 24, 2021
Morphometric Analysis of Mast Cells in Tumor Predicts Recurrence of Hepatocellular Carcinoma After Liver TransplantationNataliya Rohr-Udilova, Kaoru Tsuchiya, Gerald Timelthaler, et al.
Plos One|February 16, 2019
Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive proceduresHitomi Takada, Masayuki Kurosaki, Hiroyuki Nakanishi, et al.
Journal of Viral Hepatitis|January 23, 2021
Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatmentSakura Kirino, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Gastroenterology|May 13, 2008
Potential relevance of cytoplasmic viral sensors and related regulators involving innate immunity in antiviral responseYasuhiro Asahina, Namiki Izumi, Itsuko Hirayama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 22, 2018
Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts early occurrence of hepatocellular carcinoma after sustained virologic response by direct-acting antivirals for hepatitis C virusYutaka Yasui, Masayuki Kurosaki, Yasuyuki Komiyama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 15, 2010
A predictive model of response to peginterferon ribavirin in chronic hepatitis C using classification and regression tree analysisMasayuki Kurosaki, Kotaro Matsunaga, Itsuko Hirayama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 24, 2002
A case of primary leiomyoma of the liver in a patient without evidence of immunosuppressionNobuhiko Kanazawa, Namiki Izumi, Kaoru Tsuchiya, et al.
Hepatology (Baltimore, Md.)|April 9, 2013
α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis CYasuhiro Asahina, Kaoru Tsuchiya, Takashi Nishimura, et al.
Pageof 15

Showing results (61-70 of 149) with videos related to

Sort By:
Pageof 15
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2018
Prediction of Hepatocellular Carcinoma After Sustained Virological Responses Using Magnetic Resonance ElastographyMayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Liver Cancer|October 9, 2025
Primary Analysis of a Phase II Study of Atezolizumab plus Bevacizumab for TACE-Unsuitable Patients with Tumor Burden beyond Up-To-Seven Criteria in Intermediate-Stage Hepatocellular Carcinoma: REPLACEMENT StudyMasatoshi Kudo, Kazuomi Ueshima, Kaoru Tsuchiya, et al.
Hepatology Communications|September 24, 2021
Morphometric Analysis of Mast Cells in Tumor Predicts Recurrence of Hepatocellular Carcinoma After Liver TransplantationNataliya Rohr-Udilova, Kaoru Tsuchiya, Gerald Timelthaler, et al.
Plos One|February 16, 2019
Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive proceduresHitomi Takada, Masayuki Kurosaki, Hiroyuki Nakanishi, et al.
Journal of Viral Hepatitis|January 23, 2021
Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatmentSakura Kirino, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Gastroenterology|May 13, 2008
Potential relevance of cytoplasmic viral sensors and related regulators involving innate immunity in antiviral responseYasuhiro Asahina, Namiki Izumi, Itsuko Hirayama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 22, 2018
Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts early occurrence of hepatocellular carcinoma after sustained virologic response by direct-acting antivirals for hepatitis C virusYutaka Yasui, Masayuki Kurosaki, Yasuyuki Komiyama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 15, 2010
A predictive model of response to peginterferon ribavirin in chronic hepatitis C using classification and regression tree analysisMasayuki Kurosaki, Kotaro Matsunaga, Itsuko Hirayama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 24, 2002
A case of primary leiomyoma of the liver in a patient without evidence of immunosuppressionNobuhiko Kanazawa, Namiki Izumi, Kaoru Tsuchiya, et al.
Hepatology (Baltimore, Md.)|April 9, 2013
α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis CYasuhiro Asahina, Kaoru Tsuchiya, Takashi Nishimura, et al.
Pageof 15